Thursday, February 2, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Battelle Fills Central Role in Military’s Medical Countermeasure Enterprise

by Global Biodefense Staff
May 31, 2016
JPEO-CBD Medical Countermeasures

JPEO-CBD Medical CountermeasuresThe U.S. Army’s Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) has again chosen Battelle to perform critical medical countermeasures research to protect servicemembers against dangerous infectious disease and chemical threats.

The new award is part of an OASIS contract mechanism that is worth up to $59 million, including all options, over the next five years.

For decades, Battelle has conducted research designed to protect the military from such threats. Frequently, the vaccines and therapeutics developed and tested on these programs then make their way to protecting the civilian populace.

Read more: Battelle Wins Chemical and Biological Defense JE-CLaSS Contract

Work covered by this latest contract includes development of vaccines for potentially weaponized pathogens such as plague, equine encephalitis, and filovirus, and medical countermeasures against multiple nerve agents and poisonous toxins used in chemical warfare.

“We’re proud of the work we do at Battelle to protect people from threats like the Ebola and Zika viruses or ricin,” said Julie Swick, general manager for Battelle’s Life Sciences Research group. “Our dedicated employees come into work every day knowing they are contributing solutions to important, worldwide problems.”

Read more: Battelle Researchers Gear Up for Zika

Battelle operates the world’s largest non-governmental containment laboratories – laboratories that are equipped to characterize, assess, model, predict and measure threats. These capabilities help clients deliver effective diagnostic and therapeutic solutions for the potential victims of chemical and biological warfare, and of pandemic diseases.

As a global leader in life sciences research, Battelle has comprehensive experience in developing, validating and performing nonclinical and clinical assays; biologics development of therapeutic proteins, vaccines and other biopharmaceutical molecules; and general and inhalation toxicology analysis.

Battelle is an official sponsor of Global Biodefense.

Tags: AntitoxinsAwardsBattelleRicinVaccines

Related Posts

DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies
Medical Countermeasures

NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC